June 4, 2018 by Chain Drug Review
Donald Trump, drug prices
Issue 06-04-2018

WASHINGTON — The White House last month steered clear of extreme measures in issuing a plan to cut drug prices. While President Donald Trump called the proposal “the most sweeping action in history to lower the price of prescription drugs for the American people,” the plan left industry stakeholders relieved. Pharmaceutical company stocks even gained
March 20, 2018 by Chain Drug Review
Donald Trump, NACDS, National Association of Chain Drug Stores, opioid abuse, opioid prescribing, Steve Anderson, Stop Opioids Abuse
Leading Headlines, Pharmacy, Retail News

ARLINGTON, Va. — The National Association of Chain Drug Stores applauded President Donald Trump’s new program to combat the drug abuse epidemic, dubbed “Stop Opioids Abuse and Reduce Drug Supply and Demand.” Announced by yesterday, the Stop Opioids Abuse plan targets what the White House said are key drivers of the opioid abuse crisis, including
July 10, 2017 by Chain Drug Review
Charlie Baker, Chris Christie, Comprehensive Addiction and Recovery Act, Donald Trump, drug abuse, Ensuring Patient Access and Effective Drug Enforcement Act, NACDS, National Association of Chain Drug Stores, opioid abuse, Patrick Kennedy, President's Commission on Combating Drug Addiction and the Opioid Epidemic, Roy Cooper, Steve Anderson, video
Featured Articles, Leading Headlines, Pharmacy, Retail News, Videos

ARLINGTON, Va. — The National Association of Chain Drug Stores described retail pharmacy as a strong partner in the fight against drug abuse in a letter to New Jersey Gov. Chris Christie, chairman of the President’s Commission on Combating Drug Addiction and the Opioid Epidemic. NACDS president and chief executive officer Steve Anderson noted in
May 4, 2017 by Geoff Walden and Chain Drug Review
Affordable Care Act, American Health Care Act, B. Douglas Hoey, Donald Trump, Nancy Pelosi, National Community Pharmacists Association, Obamacare, Paul Ryan
Featured Articles, Leading Headlines, Pharmacy, Retail News

WASHINGTON — The House of Representatives today narrowly approved a bill to dismantle the Affordable Care Act. Legislators voted 217-213 to overturn many of the law’s popular consumer protections, eliminate the individual mandate, and recast the insurance market. “This bill delivers on the promises that we have made to the American people,” said House Speaker
February 1, 2017 by CDR Blog and Chain Drug Review
American Pharmacists Association, APhA, Department of Health and Human Services, Donald Trump, HHS secretary nominee, Pharmacy and Medically Underserved Areas Enhancement Act, provider status, Tom Menighan, Tom Price
CDR Blog

Rep. Tom Price (R., Ga.) had a tense confirmation hearing in the Senate last week for his nomination by President Donald Trump as secretary of the Department of Health and Human Services (HHS). But he got a thumbs-up from the American Pharmacists Association (APhA) on at least one count: pharmacists’ place in the U.S. health
January 31, 2017 by Chain Drug Review
Donald Trump, pharmaceutical industry, Pharmaceutical Research and Manufacturers of America, PhRMA, Stephen Ubl, video
Videos

In a meeting with pharmaceutical industry leaders, President Donald Trump decried the high cost of drugs but said his administration would work to make it easier to get new, innovative medications to market. The Pharmaceutical Research and Manufacturers of America (PhRMA), which along with drug company executives met with Trump at the White House on
January 17, 2017 by Steve Anderson and Chain Drug Review
ACA, Affordable Care Act, Donald Trump, Medicaid pharmacy reimbursement, NACDS, NACDS RxIMPACT, National Association of Chain Drug Stores, Pharmacy and Medically Underserved Areas Enhancement Act, Seema Verma, Steve Anderson, Tom Price
Opinion

I will spare you the introductory paragraph that attempts eloquence. Let’s get right to the point. In NACDS’ view, 2017 could be one of the most pivotal years in health care policy and in pharmacy patient care. NACDS not only is ready to advocate for pharmacy in this unprecedented environment; that vital work already is
January 16, 2017 by Greg Jacobson and Chain Drug Review
ACA, Affordable Care Act, Chris Collins, Donald Trump, Mike Pence, Obamacare
2017, Issue 01-16-2017, Issues, News

WASHINGTON — Republicans in the Senate and House of Representatives are aggressively pushing ahead with measures to repeal the Affordable Care Act despite the fact that they have no coherent alternative to replace it. Health care industry analysts and trade associations have warned that repealing or gutting the law without an adequate substitute could create
January 16, 2017 by Jeffrey Woldt and Chain Drug Review
ACA, Affordable Care Act, Barack Obama, Donald Trump, Jeffrey Woldt, Mike Pence, Obamacare, retail pharmacies
2017, Issue 01-16-2017, Issues, Leading Headlines, Opinion

After stumbling out of the gate early this month with an ill-conceived bid to hamstring the Office of Congressional Ethics (a plan that roused a chorus of critics, including President-elect Donald Trump, and was quickly withdrawn), Republicans in the House, along with their colleagues in the Senate, regained their footing and set about the business
January 12, 2017 by CDR Blog and Chain Drug Review
B. Douglas Hoey, Donald Trump, drug industry, drug pricing, National Community Pharmacists Association, NCPA, PBMs, pharmaceutical industry, pharmacy benefit managers, prescription drug prices
CDR Blog

Donald Trump briefly touched on the pharmaceutical industry in his first major press conference since being elected president. In the news conference yesterday at Trump Tower in Manhattan, Trump talked about drug companies relocating overseas and referred to the rising cost of pharmaceuticals. “We’ve got to get our drug industry back,” Trump said after discussing
January 11, 2017 by CDR Blog and Chain Drug Review
A.G. Lafley, David Shulkin, Donald Trump, Procter & Gamble, Robert McDonald, Secretary of Veterans Affairs, Veterans Administration
CDR Blog

It looks like the nearly two-and-a-half-year run of former Procter & Gamble chairman and CEO Robert McDonald as Secretary of Veterans Affairs is coming to an end. President-elect Donald Trump on Wednesday nominated David Shulkin, currently undersecretary for health at VA, to take the reins from McDonald, who has served as VA secretary since the
January 10, 2017 by Chain Drug Review
Affordable Care Act, Alex Gourlay, Alpesh Patel, Bob Narveson, Brian Nightengale, Brian Unmacht, Carmen Churcott, chain drug industry, Clint Mahlman, Donald Trump, Helena Foulkes, John Fiacco, John Figueroa, Lynne Fruth, Martin Otto, Mike Eby, Mike Wysong, National Association of Chain Drug Stores, Richard Brennan, Richard Willis, Robert Mauch, Steve Lawrence, Trump administration
Business, Featured Articles, Leading Headlines, Retail News

“The times they are a changin’,” Nobel laureate Bob Dylan sang in 1964. It’s as true now as it was 53 years ago, especially for the chain drug industry. With the incoming administration of Donald Trump, all bets are off with health care. The Affordable Care Act appears set for demise, but no one in
January 3, 2017 by David Farber and Chain Drug Review
Affordable Care Act, David Farber, Donald Trump, drug pricing, King & Spalding, Medicaid, Medicare, Obamacare, Trump administration
2017, Issue 01-02-2017, Issues, Leading Headlines, Opinion

The January 20, 2017, inauguration of President Trump as the nation’s 45th president is certain to bring with it changes in the health care environment, which may impact pharmacy in a variety of ways. As important as the new administration, however, is the fact that a “unified” government will take over in Washington, with Republicans
December 19, 2016 by Chain Drug Review
Affordable Care Act, American Pharmacists Association, Donald Trump, National Alliance of State Pharmacy Associations, National Association of Chain Drug Stores, National Community Pharmacists Association, Trump administration
Leading Headlines, Pharmacy, Retail News

WASHINGTON, D.C. — Sensing change in the air, a group of pharmacy associations have called on the incoming Trump administration and congressional leaders to recognize the role that pharmacies play in the nation’s health care system. In a letter to the new federal power structure, the National Association of Chain Drug Stores (NACDS), National Community